National Diabetes Statistics Report 2020. Estimates of diabetes and its burden in the United States. Published online 2020:32
Only 1 in 4 Adults with diagnosed diabetes achieve combined diabetes care goals | Diabetes | CDC. Published November 13, 2020. Accessed September 28, 2021. https://www.cdc.gov/diabetes/research/reports/diabetes-abcs.html
Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72. https://doi.org/10.1089/dia.2018.0384.
CAS Article PubMed PubMed Central Google Scholar
Addressing health disparities in diabetes | Diabetes | CDC. Published August 11, 2021. Accessed November 15, 2021. https://www.cdc.gov/diabetes/disparities.html
Association AD. Economic costs of diabetes in the U.S. In 2017. Diabetes Care. 2018;41(5):917–28. https://doi.org/10.2337/dci18-0007.
Nathan DM, Group for the DR. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9–16. https://doi.org/10.2337/dc13-2112
Chamberlain JJ, Rhinehart AS, Shaefer CF, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American diabetes association standards of medical care in diabetes. Ann Intern Med. 2016;164(8):542–52. https://doi.org/10.7326/M15-3016.
Lai CW, Lipman TH, Willi SM, Hawkes CP. Racial and ethnic disparities in rates of continuous glucose monitor initiation and continued use in children with type 1 diabetes. Diabetes Care. 2021;44(1):255–7. https://doi.org/10.2337/dc20-1663.
Agarwal S, Schechter C, Gonzalez J, Long JA. Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(4):306–13. https://doi.org/10.1089/dia.2020.0338.
CAS Article PubMed PubMed Central Google Scholar
Addala A, Auzanneau M, Miller K, et al. A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care. 2021;44(1):133–40. https://doi.org/10.2337/dc20-0257.
Addala A, Hanes S, Naranjo D, Maahs DM, Hood KK. Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the united states: findings from the gatekeeper study. J Diabetes Sci Technol. 2021;15(5):1027–33. https://doi.org/10.1177/19322968211006476.
Article PubMed PubMed Central Google Scholar
Golden SH, Joseph JJ, Hill-Briggs F. Casting a health equity lens on endocrinology and diabetes. J Clin Endocrinol Metab. 2021;106(4):e1909–16. https://doi.org/10.1210/clinem/dgaa938.
Dang YH, Patel-Shori NM, Barros M, Yu D. Good literacy to enhance response in diabetes mellitus (GLITTER-DM). Innov Pharm. 2020;11(3):https://doi.org/10.24926/iip.v11i3.2406
Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002;288(4):475–82. https://doi.org/10.1001/jama.288.4.475.
Agarwal S, Crespo-Ramos G, Long JA, Miller VA. “I didn’t really have a choice”: qualitative analysis of racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther. 2021;23(9):616–22. https://doi.org/10.1089/dia.2021.0075.
CAS Article PubMed Google Scholar
Wong JC, Foster NC, Maahs DM, et al. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014;37(10):2702–9. https://doi.org/10.2337/dc14-0303.
Article PubMed PubMed Central Google Scholar
Tong T, Myers AK, Bissoonauth AA, Pekmezaris R, Kozikowski A. Identifying the barriers and perceptions of non-Hispanic black and Hispanic/Latino persons with uncontrolled type 2 diabetes for participation in a home Telemonitoring feasibility study: a quantitative analysis of those who declined participation, withdrew or were non-adherent. Ethn Health. 2020;25(4):485–94. https://doi.org/10.1080/13557858.2019.1566520.
Isaacs D, Bellini NJ, Biba U, Cai A, Close KL. Health care disparities in use of continuous glucose monitoring. Diabetes Technol Ther. 2021;23(S3):S81–7. https://doi.org/10.1089/dia.2021.0268.
Association AD. 7. Diabetes technology: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S85-S99. https://doi.org/10.2337/dc21-S007
Grunberger G, Handelsman Y, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College Of Endocrinology 2018 position statement on integration of insulin pumps and continuous glucose monitoring in patients with diabetes mellitus. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2018;24(3):302–8. https://doi.org/10.4158/PS-2017-0155.
Maiorino MI, Signoriello S, Maio A, et al. Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146–56. https://doi.org/10.2337/dc19-1459.
CAS Article PubMed Google Scholar
Miller KM, Beck RW, Foster NC, Maahs DM. HbA1c levels in type 1 diabetes from early childhood to older adults: a deeper dive into the influence of technology and socioeconomic status on HbA1c in the T1D exchange clinic registry findings. Diabetes Technol Ther. 2020;22(9):645–50. https://doi.org/10.1089/dia.2019.0393.
Article PubMed PubMed Central Google Scholar
Walker AF, Hood KK, Gurka MJ, et al. Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes. Diabetes Care. Published online May 17, 2021:dc202753. https://doi.org/10.2337/dc20-2753
Anderson JE, Gavin JR, Kruger DF. Current eligibility requirements for CGM coverage Are harmful, costly, and unjustified. Diabetes Technol Ther. 2020;22(3):169–73. https://doi.org/10.1089/dia.2019.0303.
Article PubMed PubMed Central Google Scholar
Wan W, Skandari MR, Minc A, et al. Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial. Diabetes Care. 2018;41(6):1227–34. https://doi.org/10.2337/dc17-1821.
CAS Article PubMed PubMed Central Google Scholar
Cameron C, Coyle D, Ur E, Klarenbach S. Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin. CMAJ Can Med Assoc J. 2010;182(1):28–34. https://doi.org/10.1503/cmaj.090765.
Alotaibi A, Al Khalifah R, McAssey K. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Pediatr Diabetes. 2020;21(7):1256–67. https://doi.org/10.1111/pedi.13088.
CAS Article PubMed Google Scholar
Janez A, Battelino T, Klupa T, Kocsis G, Kuricová M, Lalić N, Stoian AP, Prázný M, Rahelić D, Šoupal J, Tankova T, Zelinska N. Panel urges expanded technology access for people with type 1 diabetes. Accessed November 24, 2021. https://www.univadis.com/viewarticle/panel-urges-expanded-technology-access-for-people-with-type-1-diabetes-4fceb6a6-1eb6-38ca-8d88-f546ec0d3e89
Hussain T, Akle M, Nagelkerke N, Deeb A. Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy. SAGE Open Med. 2017;5:2050312117694938. https://doi.org/10.1177/2050312117694938.
Article PubMed PubMed Central Google Scholar
Bailey TS, Stone JY. A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice. Expert Opin Drug Deliv. 2017;14(5):697–703. https://doi.org/10.1080/17425247.2017.1313831.
CAS Article PubMed Google Scholar
O’Connor MR, Carlin K, Coker T, Zierler B, Pihoker C. Disparities in insulin pump therapy persist in youth with type 1 diabetes despite rising overall pump use rates. J Pediatr Nurs. 2019;44:16–21. https://doi.org/10.1016/j.pedn.2018.10.005.
Puckett C, Wong JC, Daley TC, Cossen K. How organizations shape medical technology allocation: Insulin pumps and pediatric patients with type 1 diabetes. Soc Sci Med. 1982;2020(249):112825. https://doi.org/10.1016/j.socscimed.2020.112825.
NCD - Infusion Pumps (280.14). Accessed November 17, 2021. https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=223&ncdver=2
Lee SWH, Chan CKY, Chua SS, Chaiyakunapruk N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network meta-analysis. Sci Rep. 2017;7:12680. https://doi.org/10.1038/s41598-017-12987-z.
CAS Article PubMed PubMed Central Google Scholar
Verhoeven F, Tanja-Dijkstra K, Nijland N, Eysenbach G, van Gemert-Pijnen L. Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review. J Diabetes Sci Technol. 2010;4(3):666–84. https://doi.org/10.1177/193229681000400323.
Article PubMed PubMed Central Google Scholar
Medicare and Medicaid Programs; Policy and regulatory revisions in response to the COVID-19 public health emergency. Federal register. Published April 6, 2020. Accessed November 24, 2021. https://www.federalregister.gov/documents/2020/04/06/2020-06990/medicare-and-medicaid-programs-policy-and-regulatory-revisions-in-response-to-the-covid-19-public
Lu H, Holt JB, Cheng YJ, Zhang X, Onufrak S, Croft JB. Population-based geographic access to endocrinologists in the United States, 2012. BMC Health Serv Res. 2015;15:541. https://doi.org/10.1186/s12913-015-1185-5.
Article PubMed PubMed Central Google Scholar
Su D, Zhou J, Kelley MS, et al. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract. 2016;116:136–48. https://doi.org/10.1016/j.diabres.2016.04.019.
Isaacs T, Hunt D, Ward D, Rooshenas L, Edwards L. The inclusion of ethnic minority patients and the role of language in telehealth trials for type 2 diabetes: a systematic review. J Med Internet Res. 2016;18(9):e6374. https://doi.org/10.2196/jmir.6374.
Myers A, Presswala L, Bissoonauth A, et al. Telemedicine for disparity patients with diabetes: the feasibility of utilizing telehealth in the management of uncontrolled type 2 diabetes in black and Hispanic disparity patients; a pilot study. J Diabetes Sci Technol. 2020;15(5):1034–41. https://doi.org/10.1177/1932296820951784.
Article PubMed PubMed Central Google Scholar
Carter EL, Nunlee-Bland G, Callender C. A patient-centric, provider-assisted diabetes telehealth self-management intervention for urban minorities. Perspect Health Inf Manag AHIMA Am Health Inf Manag Assoc. 2011;8(Winter):1b.
Weinstock RS, Teresi JA, Goland R, et al. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the informatics for diabetes education and telemedicine (IDEATel) study. Diabetes Care. 2011;34(2):274–9. https://doi.org/10.2337/dc10-1346.
Article PubMed PubMed Central Google Scholar
Oseran AS, Rao K, Chang Y, et al. HbA1c-triggered endocrinology electronic consultation for type 2 diabetes management. J Gen Intern Med. Published online October 4, 2021. https://doi.org/10.1007/s11606-021-07157-x
Patel PS, Jiang B, Marcelli M, Mediwala SN, Vasudevan MM. Electronic consultation: an effective alternative to in-person clinical care for patients with diabetes mellitus. J Diabetes Sci Technol. 2019;13(1):152–3. https://doi.org/10.1177/1932296818807472.
Heitkemper EM, Mamykina L, Travers J, Smaldone A. Do health information technology self-management interventions improve glycemic control in medically underserved adults with diabetes? A systematic review and meta-analysis. J Am Med Inform Assoc JAMIA. 2017;24(5):1024–35. https://doi.org/10.1093/jamia/ocx025.
留言 (0)